| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Glycoproteins | 22 | 2018 | 370 | 6.670 |
Why?
|
| Molecular Chaperones | 10 | 2017 | 81 | 3.400 |
Why?
|
| Membrane Proteins | 8 | 2020 | 617 | 3.200 |
Why?
|
| T-Lymphocytes, Regulatory | 9 | 2020 | 199 | 2.940 |
Why?
|
| Neoplasms | 15 | 2020 | 1667 | 2.580 |
Why?
|
| Endoplasmic Reticulum | 10 | 2017 | 148 | 1.960 |
Why?
|
| Carcinogenesis | 5 | 2020 | 124 | 1.720 |
Why?
|
| HSP90 Heat-Shock Proteins | 7 | 2021 | 46 | 1.640 |
Why?
|
| Blood Platelets | 4 | 2020 | 284 | 1.560 |
Why?
|
| Immunotherapy | 6 | 2021 | 215 | 1.500 |
Why?
|
| Transforming Growth Factor beta | 5 | 2022 | 384 | 1.210 |
Why?
|
| Mice | 32 | 2020 | 8474 | 1.190 |
Why?
|
| Colonic Neoplasms | 4 | 2021 | 299 | 1.170 |
Why?
|
| Inflammation | 4 | 2019 | 1030 | 1.160 |
Why?
|
| Animals | 42 | 2021 | 20881 | 1.100 |
Why?
|
| Lymphocytes | 2 | 2018 | 228 | 1.080 |
Why?
|
| Neutrophils | 2 | 2018 | 204 | 1.060 |
Why?
|
| Immune Tolerance | 5 | 2019 | 114 | 1.030 |
Why?
|
| Mice, Knockout | 14 | 2020 | 1692 | 1.030 |
Why?
|
| Tumor Microenvironment | 5 | 2021 | 213 | 1.000 |
Why?
|
| Dendritic Cells | 5 | 2021 | 201 | 0.890 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2018 | 629 | 0.870 |
Why?
|
| Head and Neck Neoplasms | 3 | 2018 | 561 | 0.840 |
Why?
|
| Gene Deletion | 6 | 2017 | 235 | 0.840 |
Why?
|
| Biomarkers, Tumor | 2 | 2018 | 508 | 0.820 |
Why?
|
| Proteolysis | 3 | 2020 | 97 | 0.800 |
Why?
|
| Toll-Like Receptors | 4 | 2017 | 56 | 0.760 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2021 | 79 | 0.760 |
Why?
|
| Lymphocyte Activation | 8 | 2021 | 397 | 0.740 |
Why?
|
| Colitis | 3 | 2019 | 156 | 0.720 |
Why?
|
| Unfolded Protein Response | 3 | 2017 | 70 | 0.710 |
Why?
|
| Latent TGF-beta Binding Proteins | 1 | 2020 | 14 | 0.700 |
Why?
|
| Immune Evasion | 1 | 2020 | 19 | 0.700 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 756 | 0.670 |
Why?
|
| Thrombin | 1 | 2020 | 117 | 0.670 |
Why?
|
| Tumor Escape | 2 | 2016 | 37 | 0.660 |
Why?
|
| Gene Expression Regulation | 7 | 2017 | 1293 | 0.660 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 87 | 0.640 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 1536 | 0.630 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2021 | 266 | 0.630 |
Why?
|
| Humans | 45 | 2022 | 68618 | 0.610 |
Why?
|
| Palate | 1 | 2017 | 14 | 0.600 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2017 | 16 | 0.600 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 244 | 0.600 |
Why?
|
| Neoplastic Stem Cells | 2 | 2015 | 84 | 0.600 |
Why?
|
| Transcription Factor CHOP | 1 | 2017 | 28 | 0.590 |
Why?
|
| Smad2 Protein | 1 | 2017 | 42 | 0.590 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2019 | 135 | 0.590 |
Why?
|
| eIF-2 Kinase | 1 | 2017 | 49 | 0.580 |
Why?
|
| Organogenesis | 1 | 2017 | 49 | 0.580 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 2791 | 0.570 |
Why?
|
| Gastrointestinal Tract | 2 | 2017 | 63 | 0.560 |
Why?
|
| Cell Line | 8 | 2017 | 1752 | 0.560 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 44 | 0.560 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 99 | 0.560 |
Why?
|
| Cell Line, Tumor | 11 | 2021 | 1851 | 0.550 |
Why?
|
| Macrophages | 5 | 2021 | 647 | 0.550 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 88 | 0.540 |
Why?
|
| Inflammasomes | 1 | 2016 | 39 | 0.540 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 216 | 0.540 |
Why?
|
| Oncogenes | 2 | 2016 | 71 | 0.540 |
Why?
|
| Signal Transduction | 9 | 2019 | 2689 | 0.530 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2015 | 235 | 0.520 |
Why?
|
| Homeostasis | 2 | 2017 | 291 | 0.520 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 328 | 0.520 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 284 | 0.510 |
Why?
|
| Manuscripts, Medical as Topic | 1 | 2015 | 2 | 0.510 |
Why?
|
| Hematology | 1 | 2015 | 10 | 0.500 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2015 | 38 | 0.500 |
Why?
|
| Drug Design | 1 | 2015 | 107 | 0.490 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2019 | 132 | 0.490 |
Why?
|
| B-Lymphocytes | 5 | 2021 | 329 | 0.490 |
Why?
|
| Lipopolysaccharides | 3 | 2019 | 455 | 0.490 |
Why?
|
| Protein Multimerization | 4 | 2017 | 71 | 0.490 |
Why?
|
| CD24 Antigen | 1 | 2014 | 6 | 0.480 |
Why?
|
| Immunoprecipitation | 4 | 2017 | 132 | 0.470 |
Why?
|
| Protein Binding | 6 | 2020 | 1027 | 0.470 |
Why?
|
| Medical Oncology | 1 | 2015 | 110 | 0.470 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2014 | 29 | 0.460 |
Why?
|
| Melanosomes | 1 | 2013 | 5 | 0.460 |
Why?
|
| Skin Pigmentation | 1 | 2013 | 25 | 0.450 |
Why?
|
| Myeloid Cells | 1 | 2014 | 57 | 0.450 |
Why?
|
| Melanins | 1 | 2013 | 24 | 0.450 |
Why?
|
| Wnt Signaling Pathway | 2 | 2013 | 57 | 0.450 |
Why?
|
| CD11a Antigen | 1 | 2013 | 3 | 0.450 |
Why?
|
| CD18 Antigens | 1 | 2013 | 9 | 0.450 |
Why?
|
| Liver | 2 | 2019 | 1118 | 0.440 |
Why?
|
| alpha Karyopherins | 1 | 2013 | 2 | 0.440 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 186 | 0.420 |
Why?
|
| Antineoplastic Agents | 4 | 2017 | 1070 | 0.420 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2012 | 8 | 0.410 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2014 | 163 | 0.410 |
Why?
|
| Basophils | 1 | 2012 | 57 | 0.410 |
Why?
|
| Interleukin-2 | 3 | 2018 | 133 | 0.410 |
Why?
|
| Apoptosis | 7 | 2019 | 1641 | 0.410 |
Why?
|
| Immunity, Cellular | 4 | 2021 | 80 | 0.400 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 498 | 0.390 |
Why?
|
| Blotting, Western | 5 | 2017 | 954 | 0.390 |
Why?
|
| Melanoma, Experimental | 4 | 2021 | 95 | 0.380 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 334 | 0.370 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2020 | 91 | 0.320 |
Why?
|
| Cell Membrane | 3 | 2020 | 525 | 0.320 |
Why?
|
| Mice, Inbred BALB C | 3 | 2020 | 532 | 0.320 |
Why?
|
| HIV Infections | 4 | 2019 | 791 | 0.310 |
Why?
|
| Prognosis | 4 | 2020 | 2093 | 0.310 |
Why?
|
| Cytokines | 6 | 2020 | 866 | 0.310 |
Why?
|
| Mice, Inbred NOD | 3 | 2016 | 138 | 0.310 |
Why?
|
| Th17 Cells | 2 | 2020 | 116 | 0.300 |
Why?
|
| Female | 16 | 2022 | 38074 | 0.300 |
Why?
|
| RNA Interference | 4 | 2017 | 266 | 0.290 |
Why?
|
| Mice, Transgenic | 8 | 2021 | 1033 | 0.290 |
Why?
|
| Influenza Vaccines | 2 | 2019 | 56 | 0.280 |
Why?
|
| China | 2 | 2018 | 138 | 0.280 |
Why?
|
| HEK293 Cells | 3 | 2018 | 326 | 0.270 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2017 | 24 | 0.270 |
Why?
|
| Survival Rate | 3 | 2020 | 1056 | 0.270 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2017 | 226 | 0.270 |
Why?
|
| CD11c Antigen | 2 | 2017 | 18 | 0.270 |
Why?
|
| T-Lymphocytes | 3 | 2019 | 597 | 0.260 |
Why?
|
| Flow Cytometry | 4 | 2015 | 489 | 0.240 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 492 | 0.240 |
Why?
|
| Cell Proliferation | 6 | 2019 | 1174 | 0.240 |
Why?
|
| Antibodies, Monoclonal | 3 | 2015 | 511 | 0.240 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 1174 | 0.230 |
Why?
|
| Chromatography, Liquid | 2 | 2017 | 120 | 0.230 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2017 | 139 | 0.220 |
Why?
|
| Bacterial Translocation | 3 | 2019 | 27 | 0.220 |
Why?
|
| Disease Progression | 2 | 2020 | 1038 | 0.220 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2022 | 756 | 0.210 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 475 | 0.200 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 217 | 0.200 |
Why?
|
| Immunity, Humoral | 3 | 2019 | 42 | 0.200 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2022 | 63 | 0.200 |
Why?
|
| Immunoblotting | 2 | 2013 | 254 | 0.190 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 2550 | 0.190 |
Why?
|
| Phosphorylation | 3 | 2020 | 1200 | 0.180 |
Why?
|
| Serum Response Factor | 1 | 2020 | 15 | 0.180 |
Why?
|
| Actin Cytoskeleton | 1 | 2020 | 37 | 0.180 |
Why?
|
| Antibodies, Neutralizing | 2 | 2017 | 46 | 0.180 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 102 | 0.170 |
Why?
|
| Hepatic Stellate Cells | 1 | 2020 | 53 | 0.170 |
Why?
|
| Hemoglobins | 1 | 2020 | 120 | 0.170 |
Why?
|
| Interleukin-15 | 2 | 2017 | 66 | 0.170 |
Why?
|
| Lymphocyte Count | 2 | 2017 | 53 | 0.170 |
Why?
|
| Beijing | 1 | 2018 | 2 | 0.170 |
Why?
|
| Jurkat Cells | 1 | 2019 | 59 | 0.160 |
Why?
|
| Staphylococcus | 1 | 2019 | 29 | 0.160 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2019 | 42 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2020 | 237 | 0.160 |
Why?
|
| Neoplasm Metastasis | 3 | 2015 | 306 | 0.160 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-6 | 2 | 2015 | 8 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 126 | 0.160 |
Why?
|
| Immunity, Innate | 2 | 2019 | 156 | 0.160 |
Why?
|
| History, 21st Century | 1 | 2018 | 127 | 0.160 |
Why?
|
| Sex Factors | 2 | 2021 | 1266 | 0.160 |
Why?
|
| Gene Expression | 3 | 2021 | 770 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 700 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 215 | 0.160 |
Why?
|
| Transcription Factors | 2 | 2020 | 753 | 0.150 |
Why?
|
| Male | 11 | 2021 | 37321 | 0.150 |
Why?
|
| Cell Movement | 3 | 2020 | 630 | 0.150 |
Why?
|
| Models, Animal | 2 | 2019 | 252 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 1 | 2018 | 41 | 0.150 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 35 | 0.150 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 13 | 0.150 |
Why?
|
| L-Selectin | 1 | 2017 | 28 | 0.150 |
Why?
|
| Polylysine | 1 | 2017 | 13 | 0.150 |
Why?
|
| CTLA-4 Antigen | 1 | 2017 | 45 | 0.150 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2017 | 7 | 0.150 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2017 | 7 | 0.150 |
Why?
|
| Cleft Palate | 1 | 2017 | 34 | 0.140 |
Why?
|
| Poly I-C | 1 | 2017 | 20 | 0.140 |
Why?
|
| Peptides | 3 | 2017 | 455 | 0.140 |
Why?
|
| Heterozygote | 1 | 2017 | 174 | 0.140 |
Why?
|
| Interleukin-7 | 1 | 2017 | 18 | 0.140 |
Why?
|
| Glycolysis | 1 | 2017 | 79 | 0.140 |
Why?
|
| Mutation | 3 | 2017 | 1213 | 0.140 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2017 | 50 | 0.140 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 176 | 0.140 |
Why?
|
| NLR Proteins | 1 | 2016 | 3 | 0.140 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 373 | 0.140 |
Why?
|
| Monocytes | 2 | 2014 | 210 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 301 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2016 | 18 | 0.140 |
Why?
|
| Cancer Vaccines | 1 | 2017 | 61 | 0.140 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 21 | 0.140 |
Why?
|
| Cysteine | 1 | 2017 | 112 | 0.140 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 159 | 0.140 |
Why?
|
| Caspase 1 | 1 | 2016 | 22 | 0.140 |
Why?
|
| Pancreas | 1 | 2018 | 225 | 0.140 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 22 | 0.140 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2017 | 66 | 0.140 |
Why?
|
| Protein Transport | 1 | 2017 | 280 | 0.140 |
Why?
|
| Tissue Array Analysis | 1 | 2016 | 53 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 200 | 0.140 |
Why?
|
| Heterografts | 1 | 2016 | 70 | 0.140 |
Why?
|
| Animals, Newborn | 1 | 2017 | 396 | 0.140 |
Why?
|
| Middle Aged | 7 | 2021 | 21147 | 0.140 |
Why?
|
| Drosophila melanogaster | 1 | 2017 | 80 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2019 | 434 | 0.140 |
Why?
|
| HIV-1 | 2 | 2015 | 177 | 0.140 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 142 | 0.130 |
Why?
|
| Cell Survival | 3 | 2013 | 901 | 0.130 |
Why?
|
| Sepsis | 1 | 2019 | 233 | 0.130 |
Why?
|
| Lipopolysaccharide Receptors | 2 | 2014 | 23 | 0.130 |
Why?
|
| Cluster Analysis | 2 | 2015 | 219 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 376 | 0.130 |
Why?
|
| Klebsiella Infections | 1 | 2015 | 13 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 951 | 0.130 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2015 | 32 | 0.130 |
Why?
|
| Pneumonia, Bacterial | 1 | 2015 | 19 | 0.130 |
Why?
|
| Vaccination | 1 | 2017 | 189 | 0.130 |
Why?
|
| Streptococcus pneumoniae | 1 | 2015 | 32 | 0.130 |
Why?
|
| Integrins | 1 | 2015 | 115 | 0.130 |
Why?
|
| Adenine | 1 | 2015 | 46 | 0.130 |
Why?
|
| Purines | 1 | 2015 | 39 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 37 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 710 | 0.130 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2015 | 12 | 0.120 |
Why?
|
| Centrioles | 1 | 2015 | 7 | 0.120 |
Why?
|
| Pneumococcal Infections | 1 | 2015 | 30 | 0.120 |
Why?
|
| Diethylnitrosamine | 1 | 2014 | 10 | 0.120 |
Why?
|
| Alkylating Agents | 1 | 2014 | 15 | 0.120 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2015 | 10 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2017 | 368 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 561 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 349 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 322 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2018 | 7277 | 0.120 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 69 | 0.120 |
Why?
|
| Genotype | 1 | 2017 | 786 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 170 | 0.120 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 94 | 0.120 |
Why?
|
| Lymphoma | 1 | 2015 | 116 | 0.120 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 114 | 0.120 |
Why?
|
| Kidney | 1 | 2019 | 945 | 0.120 |
Why?
|
| Cell Differentiation | 4 | 2021 | 1034 | 0.120 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 800 | 0.120 |
Why?
|
| Interleukin-23 | 1 | 2013 | 13 | 0.120 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 60 | 0.120 |
Why?
|
| Protein Engineering | 1 | 2014 | 35 | 0.110 |
Why?
|
| Interferon-gamma | 1 | 2015 | 241 | 0.110 |
Why?
|
| Mucous Membrane | 1 | 2013 | 66 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 332 | 0.110 |
Why?
|
| Interleukin-17 | 1 | 2013 | 62 | 0.110 |
Why?
|
| Bromodeoxyuridine | 1 | 2013 | 37 | 0.110 |
Why?
|
| HCT116 Cells | 1 | 2013 | 63 | 0.110 |
Why?
|
| Calcium | 1 | 2017 | 929 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2015 | 431 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 481 | 0.110 |
Why?
|
| Databases, Genetic | 1 | 2013 | 52 | 0.110 |
Why?
|
| DNA Repair | 1 | 2013 | 127 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 127 | 0.110 |
Why?
|
| Colon | 1 | 2013 | 168 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 230 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1664 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 282 | 0.110 |
Why?
|
| Data Mining | 1 | 2013 | 45 | 0.110 |
Why?
|
| Multiple Myeloma | 1 | 2013 | 92 | 0.110 |
Why?
|
| Sex Characteristics | 1 | 2014 | 295 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2013 | 87 | 0.100 |
Why?
|
| Workflow | 1 | 2013 | 100 | 0.100 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 16 | 0.100 |
Why?
|
| Periodicals as Topic | 1 | 2015 | 158 | 0.100 |
Why?
|
| Antigens | 1 | 2012 | 90 | 0.100 |
Why?
|
| Plasmids | 1 | 2013 | 258 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2012 | 93 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 199 | 0.100 |
Why?
|
| Species Specificity | 1 | 2012 | 303 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 3259 | 0.100 |
Why?
|
| Pregnancy | 1 | 2017 | 2334 | 0.100 |
Why?
|
| Binding Sites | 1 | 2013 | 631 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 196 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 268 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 778 | 0.090 |
Why?
|
| Chromatography, Gel | 1 | 2010 | 79 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 81 | 0.090 |
Why?
|
| Protein Folding | 1 | 2010 | 82 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2018 | 2673 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 261 | 0.090 |
Why?
|
| Cross-Priming | 2 | 2021 | 10 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1745 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 507 | 0.080 |
Why?
|
| Transfection | 1 | 2010 | 782 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2013 | 902 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 1173 | 0.080 |
Why?
|
| Antigen Presentation | 2 | 2019 | 76 | 0.070 |
Why?
|
| Aged | 3 | 2021 | 14862 | 0.070 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2017 | 38 | 0.070 |
Why?
|
| Influenza, Human | 2 | 2019 | 79 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 1026 | 0.070 |
Why?
|
| Interleukin-6 | 2 | 2020 | 330 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2017 | 126 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2015 | 294 | 0.060 |
Why?
|
| Transplantation, Heterologous | 2 | 2015 | 122 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2019 | 682 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 626 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2015 | 238 | 0.060 |
Why?
|
| Umbilical Cord | 1 | 2022 | 19 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 76 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1553 | 0.050 |
Why?
|
| Genes, MHC Class I | 1 | 2021 | 14 | 0.050 |
Why?
|
| Genes, MHC Class II | 1 | 2021 | 29 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2021 | 118 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2021 | 110 | 0.050 |
Why?
|
| Immunity | 1 | 2021 | 67 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2020 | 49 | 0.040 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2020 | 35 | 0.040 |
Why?
|
| Cecum | 1 | 2019 | 39 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2020 | 324 | 0.040 |
Why?
|
| Linear Models | 1 | 2021 | 521 | 0.040 |
Why?
|
| Germinal Center | 1 | 2019 | 13 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 68 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 35 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2019 | 59 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 150 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2018 | 36 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2020 | 483 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2018 | 64 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 947 | 0.040 |
Why?
|
| Cell Count | 1 | 2018 | 248 | 0.040 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2017 | 7 | 0.040 |
Why?
|
| Organ Size | 1 | 2018 | 242 | 0.040 |
Why?
|
| Immunotherapy, Active | 1 | 2017 | 6 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 493 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2017 | 79 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 145 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 132 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 179 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 57 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 219 | 0.030 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2015 | 5 | 0.030 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2015 | 10 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2015 | 19 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2015 | 13 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 1864 | 0.030 |
Why?
|
| RNA, Bacterial | 1 | 2015 | 30 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 2015 | 18 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 85 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 80 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2015 | 98 | 0.030 |
Why?
|
| Natural Killer T-Cells | 1 | 2015 | 7 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2015 | 53 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2015 | 17 | 0.030 |
Why?
|
| Myoblasts | 1 | 2015 | 22 | 0.030 |
Why?
|
| Pneumococcal Vaccines | 1 | 2015 | 30 | 0.030 |
Why?
|
| Leukemia, T-Cell | 1 | 2015 | 21 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 145 | 0.030 |
Why?
|
| Lymphoma, T-Cell | 1 | 2015 | 19 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2015 | 110 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2015 | 37 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 56 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 132 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 94 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2015 | 52 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 160 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2015 | 78 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 282 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 69 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 337 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2015 | 36 | 0.030 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Immunoglobulin D | 1 | 2014 | 14 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 137 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2015 | 85 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2014 | 64 | 0.030 |
Why?
|
| fas Receptor | 1 | 2014 | 54 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2015 | 129 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2014 | 32 | 0.030 |
Why?
|
| Arginine | 1 | 2015 | 102 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 132 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 420 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2014 | 75 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 1083 | 0.030 |
Why?
|
| Ligands | 1 | 2015 | 317 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 69 | 0.030 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2013 | 7 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 40 | 0.030 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2013 | 16 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 4 | 0.030 |
Why?
|
| PAX5 Transcription Factor | 1 | 2013 | 9 | 0.030 |
Why?
|
| GATA1 Transcription Factor | 1 | 2013 | 19 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 214 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2013 | 57 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2013 | 72 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 160 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 231 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 48 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2013 | 108 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 791 | 0.030 |
Why?
|
| Bacteria | 1 | 2014 | 193 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 1342 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2013 | 183 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 194 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2013 | 312 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 5300 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 434 | 0.020 |
Why?
|
| Adult | 2 | 2015 | 21403 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 5717 | 0.010 |
Why?
|